Skip to main content
Clinical Trials/NCT02089906
NCT02089906
Completed
Not Applicable

Health Status of Chinese Elderly

Abbott Nutrition3 sites in 1 country2,834 target enrollmentMarch 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malnutrition
Sponsor
Abbott Nutrition
Enrollment
2834
Locations
3
Primary Endpoint
Total skeletal muscle mass
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study is aiming to understand the prevalence and risk factors related to malnutrition and sarcopenia in Chinese elderly.

Detailed Description

The study objective is to understand the prevalence of malnutrition and sarcopenia in Chinese elderly with the cut-off points from the normal range of muscle mass and function in Chinese adults; to understand the risk factors related to malnutrition and sarcopenia in Chinese elderly; to set up a screening tool on malnutrition and sarcopenia risks in Chinese elderly.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
July 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female Chinese ages \>= 60 years.
  • Subject lives in the community for more than 12 months.
  • Subject has voluntarily signed and dated an informed consent form, approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.

Exclusion Criteria

  • Subject who did/does heavy manual labor
  • Subject who was a professional or semi-professional athlete or game player
  • Subject who has physical disabilities such as loss of hand or foot or limbs or any other physical disability which may affect the muscle mass by the opinion of the study physician.
  • Subject has an implanted electronic device or orthopedic metal implantations, such as pacemaker, cardiac defibrillator, subcutaneous injection pump, or metal hip, metal knee joint, metal fracture internal fixation, etc.
  • Subject who has active hyperthyroidism or hypothyroidism and needs medication treatment as by self-report.
  • Subject who has severe heart dysfunction or renal dysfunction with significant sodium water retention or edema by the opinion of study physicians.
  • Subject who takes hormones except for external application of glucocorticoids.
  • Subject who takes diuretics except for using a stable dose for at least 3 weeks as a part of hypertension treatment.
  • Subject who has later stage of malignancies with cachexia by the opinion of study physicians.
  • Subject has any other disease or situation who should not to participate in the study by the opinion of study physicians.

Outcomes

Primary Outcomes

Total skeletal muscle mass

Time Frame: Test Visit 1 (~ Day 7)

bioelectric impedance absorptiometry (BIA)

Secondary Outcomes

  • Total body fat(Test Visit 1 (~Day 7) and Test Visit 2 (~ Day 17))
  • Total skeletal muscle mass(Test Visit 2 (~ Day 17))
  • Total body fat free mass(Test Visit 1 (~ Day 7) and Test Visit 2 (~ Day 17))
  • Hand grip strength(Test Visit 1 (~ Day 7))
  • Gait speed(Test Visit 1 (~ Day 7))

Study Sites (3)

Loading locations...

Similar Trials